TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT04090736: completion date: 2025-06-30 → 2026-07-30.
Clinical trial NCT04090736: completion date: 2025-06-30 → 2026-07-30.
Clinical trial NCT07349121 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-18 3. completion date: 2028-12-01 → 2029-12-01
Clinical trial NCT06824987: enrollment: 96 → 136 participants.
Clinical trial NCT07365579 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-02 3. completion date: 2027-01-01 → 2027-06-30 4. primary completion date: 2027-01-01 → 2027-05-04 5. collaborators added: National Institute of Mental Health (NIMH)
Clinical trial NCT06096311 updates: 1. status: RECRUITING → COMPLETED 2. primary completion date: 2025-12-01 → 2024-08-07 3. enrollment: 30 → 35 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT01273610: completion date: 2026-05-19 → 2027-04-20.
Clinical trial NCT05558319 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2022-10-01 → 2022-11-10 3. collaborators added: Adknoma Health Research 4. collaborators removed: Start from scratch, Adknoma
Clinical trial NCT06100952 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-11-01 → 2026-03-17 3. primary completion date: 2025-11-01 → 2026-02-13 4. enrollment: 400 → 398 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06227546: completion date: 2026-05-01 → 2027-04-01.
Clinical trial NCT06165510 updates: 1. completion date: 2026-10-01 → 2026-11-01 2. primary completion date: 2026-06-01 → 2026-11-01